These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 25645841)
1. The Mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic molecules. Danilchanka O; Pires D; Anes E; Niederweis M Antimicrob Agents Chemother; 2015 Apr; 59(4):2328-36. PubMed ID: 25645841 [TBL] [Abstract][Full Text] [Related]
2. An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity. Danilchanka O; Sun J; Pavlenok M; Maueröder C; Speer A; Siroy A; Marrero J; Trujillo C; Mayhew DL; Doornbos KS; Muñoz LE; Herrmann M; Ehrt S; Berens C; Niederweis M Proc Natl Acad Sci U S A; 2014 May; 111(18):6750-5. PubMed ID: 24753609 [TBL] [Abstract][Full Text] [Related]
3. The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis. Mailaender C; Reiling N; Engelhardt H; Bossmann S; Ehlers S; Niederweis M Microbiology (Reading); 2004 Apr; 150(Pt 4):853-864. PubMed ID: 15073295 [TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis Toxin CpnT Is an ESX-5 Substrate and Requires Three Type VII Secretion Systems for Intracellular Secretion. Izquierdo Lafuente B; Ummels R; Kuijl C; Bitter W; Speer A mBio; 2021 Mar; 12(2):. PubMed ID: 33653883 [TBL] [Abstract][Full Text] [Related]
5. Glutamate Dehydrogenase Is Required by Mycobacterium bovis BCG for Resistance to Cellular Stress. Gallant JL; Viljoen AJ; van Helden PD; Wiid IJ PLoS One; 2016; 11(1):e0147706. PubMed ID: 26824899 [TBL] [Abstract][Full Text] [Related]
6. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages. Khan A; Sarkar S; Sarkar D Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548 [TBL] [Abstract][Full Text] [Related]
8. Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages. Idh J; Andersson B; Lerm M; Raffetseder J; Eklund D; Woksepp H; Werngren J; Mansjö M; Sundqvist T; Stendahl O; Schön T PLoS One; 2017; 12(7):e0181221. PubMed ID: 28704501 [TBL] [Abstract][Full Text] [Related]
9. Role of P27 -P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds. Bianco MV; Blanco FC; Imperiale B; Forrellad MA; Rocha RV; Klepp LI; Cataldi AA; Morcillo N; Bigi F BMC Infect Dis; 2011 Jul; 11():195. PubMed ID: 21762531 [TBL] [Abstract][Full Text] [Related]
11. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203 [TBL] [Abstract][Full Text] [Related]
12. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. Ramón-García S; Martín C; De Rossi E; Aínsa JA J Antimicrob Chemother; 2007 Mar; 59(3):544-7. PubMed ID: 17242035 [TBL] [Abstract][Full Text] [Related]
13. ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis. He L; Wang X; Cui P; Jin J; Chen J; Zhang W; Zhang Y Tuberculosis (Edinb); 2015 Mar; 95(2):149-54. PubMed ID: 25547657 [TBL] [Abstract][Full Text] [Related]
14. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry. Akselband Y; Cabral C; Shapiro DS; McGrath P J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276 [TBL] [Abstract][Full Text] [Related]
16. Drug susceptibility of Spanish Mycobacterium tuberculosis complex isolates from animals. Romero B; Aranaz A; Bezos J; Alvarez J; de Juan L; Tariq Javed M; Mateos A; Gómez-Mampaso E; Domínguez L Tuberculosis (Edinb); 2007 Nov; 87(6):565-71. PubMed ID: 17900988 [TBL] [Abstract][Full Text] [Related]
17. Development of infection model for studying intracellular gene expression of Mycobacterium tuberculosis. Alli OA; Ogbolu DO; Spreadbury CL Afr J Med Med Sci; 2009 Dec; 38(4):325-32. PubMed ID: 20499625 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis. Colangeli R; Helb D; Vilchèze C; Hazbón MH; Lee CG; Safi H; Sayers B; Sardone I; Jones MB; Fleischmann RD; Peterson SN; Jacobs WR; Alland D PLoS Pathog; 2007 Jun; 3(6):e87. PubMed ID: 17590082 [TBL] [Abstract][Full Text] [Related]
19. New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells. Abate G; Ruminiski PG; Kumar M; Singh K; Hamzabegovic F; Hoft DF; Eickhoff CS; Selimovic A; Campbell M; Chibale K Antimicrob Agents Chemother; 2015 Dec; 60(3):1216-25. PubMed ID: 26643325 [TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria. Ramos DF; Almeida da Silva PE Pharm Biol; 2010 Mar; 48(3):260-3. PubMed ID: 20645810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]